Objection to codeine reclassification may delay its rollout

+Print Archive

Objection to codeine reclassification may delay its rollout

Nurofen Plus
Reckitt Benckiser’s Nurofen Plus is one of the products likely to be affected if the recommendation for reclassifying codeine-containing medicines goes ahead
The Medicines Classification Committee has received a single objection to the recommendation made at its 63rd meeting last year that all codeine-conta